Angiotensin-converting–enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...
Since the introduction of ARBs, the question that has pervaded each clinician’s mind is whether or not these drugs serve an advantage in conditions long addressed by ACE inhibitors. Matchar et al ...
ACE inhibitors may reduce all-cause mortality in IPF patients, suggesting potential repurposing for this progressive disease. The study used electronic health records from 3579 IPF patients, matched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results